tiprankstipranks
Inotiv (DE:BS50)
FRANKFURT:BS50
Germany Market
BS50
Inotiv
RESEARCH TOOLSreports

Inotiv (BS50) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BS50 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Inotiv
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BS50 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:BS50 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BS50 Financial Forecast

BS50 Earnings Forecast

Next quarter’s earnings estimate for BS50 is -€0.40 with a range of -€0.45 to -€0.36. The previous quarter’s EPS was -€0.80. BS50 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BS50 has Performed in-line its overall industry.
Next quarter’s earnings estimate for BS50 is -€0.40 with a range of -€0.45 to -€0.36. The previous quarter’s EPS was -€0.80. BS50 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BS50 has Performed in-line its overall industry.

BS50 Sales Forecast

Next quarter’s sales forecast for BS50 is €117.23M with a range of €117.16M to €117.31M. The previous quarter’s sales results were €100.91M. BS50 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BS50 has Performed in-line its overall industry.
Next quarter’s sales forecast for BS50 is €117.23M with a range of €117.16M to €117.31M. The previous quarter’s sales results were €100.91M. BS50 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BS50 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on DE:BS50
Frank Takkinen
Lake Street
Lake Street
€1.29
Buy
215.04%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Inotiv (NASDAQ: NOTV) and Agilon Health (NYSE: AGL)
Craig-Hallum Analyst forecast on DE:BS50
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
02/06/26
Analysts Are Bullish on Top Healthcare Stocks: Iradimed (IRMD), Inotiv (NOTV)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on DE:BS50
Frank Takkinen
Lake Street
Lake Street
€1.29
Buy
215.04%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Inotiv (NASDAQ: NOTV) and Agilon Health (NYSE: AGL)
Craig-Hallum Analyst forecast on DE:BS50
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
02/06/26
Analysts Are Bullish on Top Healthcare Stocks: Iradimed (IRMD), Inotiv (NOTV)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Inotiv

3 Months
Matt HewittCraig-Hallum
Success Rate
8/24 ratings generated profit
33%
Average Return
-6.76%
Copying Matt Hewitt's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -6.76% per trade.
1 Year
Matt HewittCraig-Hallum
Success Rate
5/24 ratings generated profit
21%
Average Return
-50.55%
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 20.83% of your transactions generating a profit, with an average return of -50.55% per trade.
2 Years
Frank TakkinenLake Street
Success Rate
2/24 ratings generated profit
8%
Average Return
-71.72%
Copying Frank Takkinen's trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -71.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BS50 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
1
1
0
0
Buy
4
2
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
3
2
0
0
In the current month, BS50 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BS50 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

BS50 Stock Forecast FAQ

What is DE:BS50’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:BS50’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:BS50, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Inotiv a Buy, Sell or Hold?
      Currently, no data Available
      What is Inotiv’s share price target?
      Currently, no data Available
      What do analysts say about Inotiv?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Inotiv?
      To buy shares of DE:BS50, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.